XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
EXICURE, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.03−0.09 (-8.04%)
Close on Oct 19, 2026
- Market cap
- $6.57M
- P/E (TTM)
- –
- Dividend yield
- –
Exicure statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Exicure | Industry median |
|---|---|---|
| Market Cap | $6.74M | $166.30M |
| Enterprise Value | $5.03M | $88.19M |
| PB Ratio | 6.90 | 2.03 |
Income (trailing twelve months)
| Measure | Exicure | Industry median |
|---|---|---|
| Revenue | $0 | $58.34M |
| Operating Income | -$7.34M | -$21.40M |
| Pretax Income | -$8.92M | -$14.34M |
| Net Income | -$8.28M | -$22.46M |
| EBITDA | -$7.14M | -$16.91M |
| EPS (Diluted) | -$1.31 | -$0.83 |
Returns
| Measure | Exicure | Industry median |
|---|---|---|
| Return on Equity (ROE) | -168.4% | -53.2% |
| Return on Assets (ROA) | -55.0% | -40.9% |
| Return on Invested Capital (ROIC) | -4376.9% | -32.4% |
| Return on Capital Employed (ROCE) | -101.6% | -38.1% |
Balance sheet
| Measure | Exicure | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.72M | $61.43M |
| Net Cash (Debt) | $1.72M | $15.35M |
| Net Cash Per Share | $0.26 | $0.66 |
| Equity (Book Value) | $977.00K | $49.09M |
| Book Value Per Share | $0.15 | $1.37 |
| Tangible Book Value | -$7.21M | $23.52M |
| Working Capital | -$1.85M | $76.81M |
Financial position
| Measure | Exicure | Industry median |
|---|---|---|
| Current Ratio | 0.56 | 3.34 |
| Quick Ratio | 0.41 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Exicure | Industry median |
|---|---|---|
| Operating Cash Flow | -$6.70M | -$12.35M |
Efficiency
| Measure | Exicure | Industry median |
|---|---|---|
| Asset Turnover | 0.00 | 0.39 |
| Revenue Per Employee | $0 | $404.87K |
| Profits Per Employee | -$1.04M | -$703.34K |
| Employee Count | 8 | 74 |
Dividends and yields
| Measure | Exicure | Industry median |
|---|---|---|
| Earnings Yield | -122.9% | -23.3% |
| Buyback Yield | 0.00% | -0.59% |
| Shareholder Yield | 0.00% | 0.00% |
Shares
| Measure | Exicure | Industry median |
|---|---|---|
| Shares Outstanding | 6,546,000 | 58,127,000 |
| Shares Change (YoY) | 49.6% | 10.9% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 483,139 | 49,136,700 |
| Shares Held by Insiders | 92.6% | 11.6% |
| Shares Held by Institutions | 2.09% | 59.4% |
Taxes
| Measure | Exicure | Industry median |
|---|---|---|
| Income Tax | -$634.00K | $79.87K |
Scores
| Measure | Exicure | Industry median |
|---|---|---|
| Altman Z-Score | -27.38 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Exicure's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.